Clinical Trial Update: 68Ga-BNOTA-PRGD2 PET/CT in Evaluation of Stroke [EARLY_Phase 1]

View source ↗

Summary

This document provides an update on an early-phase (Phase 1) clinical trial evaluating the PET tracer 68Ga-BNOTA-PRGD2 for imaging stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• 68Ga-BNOTA-PRGD2

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Stroke | EARLY_Phase 1 | Status: UNKNOWN